A kind of n-methylciprofloxacin aldehyde thiosemicarbazone derivatives and its preparation method and application
A kind of technology of methyl ciprofloxacin aldehyde amino and methyl ciprofloxacin aldehyde, which is applied to N-methyl ciprofloxacin aldehyde thiosemicarbazide derivatives, N-methyl ciprofloxacin aldehyde Preparation of thiosemicarbazone derivatives, application field in antitumor drugs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] 1-cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-quinolin-4(1H)-one-3-aldehyde thiosemicarbazone (I-1), which The chemical structural formula is:
[0039]
[0040] That is, R in formula I is an H atom.
[0041]The preparation method of this compound is: take N-methylciprofloxacin C-3 aldehyde crude product (1.0g) shown in formula (V) and dissolve in absolute ethanol (20 milliliters), add thiosemicarbazide (0.5g, 5.5 mmol), reflux reaction for 12 hours, filtered while hot, washed 2 times with ethanol, washed 2 times with distilled water, dried, recrystallized with DMF-ethanol (V:V=1:3) mixed solvent, obtained light yellow crystal formula ( I-1) Product 0.66g, m.p.256~258°C. 1 H NMR (400MHz, DMSO-d 6 )δ: 11.39(s, 1H, CH=N), 8.60(s, 1H, 2-H), 8.46(s, 1H, NH), 8.32(s, 1H, NH 2 ),8.27(s,1H,NH 2 ), 7.75 (d, 1H, 5-H), 7.46 (d, 1H, 8-H), 3.70 (m, 1H, 1-N-CH), 3.24 (t, 4H, piperazine-H), 2.53 ( t,4H, piperazine-H), 2.26(s,3H, N-CH 3 ), 1.26~1.15(m,4H,CH 2 CH 2 ); M...
Embodiment 2
[0043] 1-cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-quinolin-4(1H)-one-3-aldehyde acetal 4-methylthiosemicarbazide (I-2 ), its chemical structure is:
[0044]
[0045] That is, R in formula I is a methyl group.
[0046] The preparation method of this compound is: take N-methyl ciprofloxacin aldehyde hydrazine dithioformate methyl ester (1.0 g, 2.3 mmol) shown in (VII) and dissolve in anhydrous n-butanol (20 milliliters) After adding methylamine (0.71 g, 23.0 mmol), the mixed reactants were refluxed for 12 hours, filtered while hot, and the solid was washed twice with ethanol and twice with distilled water, dried, and washed with DMF-ethanol (V:V=1: 5) Recrystallization from a mixed solvent to obtain 0.50 g of a yellow crystalline product of formula (I-2), m.p.243-245°C. 1 H NMR (400MHz, DMSO-d 6 )δ: 11.39 (s, 1H, CH=N), 8.60 (s, 1H, 2-H), 8.47~8.32 (m, 2H, 2×NH), 7.76 (d, 1H, 5-H), 7.42 (d, 1H, 8-H), 3.69 (m, 1H, 1-N-CH), 3.67 (d, 3H, NHCH 3 ), 3.24(t, 4H, pipera...
Embodiment 3
[0048] 1-cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-quinolin-4(1H)-one-3-aldehyde acetal 4-ethylthiosemicarbazide (I-3 ), its chemical structure is:
[0049]
[0050] That is, R in formula I is ethyl.
[0051] The preparation method of this compound is: take N-methyl ciprofloxacin aldehyde hydrazine dithioformate methyl ester (1.0 g, 2.3 mmol) shown in (VII) and dissolve in anhydrous n-butanol (20 milliliters) After adding ethylamine (1.04 g, 23.0 mmol), the mixed reactants were refluxed for 12 hours, filtered while hot, and the solid was washed twice with ethanol and twice with distilled water, dried, and washed with DMF-ethanol (V:V=1: 5) Recrystallization from a mixed solvent to obtain 0.55 g of a yellow crystalline product of formula (I-3), m.p.238-240°C. 1 H NMR (400MHz, DMSO-d 6 )δ: 11.32 (s, 1H, CH=N), 8.57 (s, 1H, 2-H), 8.48~8.32 (m, 2H, 2×NH), 7.76 (d, 1H, 5-H), 7.46 (d, 1H, 8-H), 3.68 (m, 1H, 1-N-CH), 3.64 (m, 3H, NHCH 2 ), 3.25(t, 4H, piperazine-H), 2....
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com